Huntington's Market Research Reports & Industry Analysis
Medications are available to help manage the symptoms of Huntington's disease, but treatments can't prevent the physical, mental and behavioral decline associated with the condition. After the onset of Huntington's disease, a person's functional abilities gradually worsen over time. The rate of disease progression and duration varies. The time from disease onset to death is often about 10 to 30 years. Juvenile onset usually results in death in fewer than 15 years.
The clinical depression associated with Huntington's disease may increase the risk of suicide. Some research suggests that the greater risk of suicide occurs before a diagnosis is made and in middle stages of the disease when a person has begun to lose independence. Eventually, a person with Huntington's disease requires help with all activities of daily living and care. Late in the disease, he or she will likely be confined to a bed and unable to speak. However, a person's understanding of surroundings and interactions remain intact for a long time.
Huntington's Industry Research & Market Reports
-
Huntington’s Disease Market Size-By Treatment - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
... 2.65 billion by 2032 with a CAGR of 19.83%. The global market for Huntington's disease is expanding as a result of significant R&D expenditures for the creation of novel products, research partnerships, and the high ... Read More
-
Saudi Arabia Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New-born Screening, Predictive & Pre-symptomatic Testing, Prenatal Testing, Others), By Disease (Sickle Cell Anemia, Thalassemia, Huntington's Disease, Cancer, Others), By
... Testing, Molecular Testing), By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals), By Region, Competition Forecast & Opportunities, 2027 Saudi Arabia genetic testing market is anticipated to register growth with an impressive ... Read More
-
Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Huntington Disease (Central Nervous System) pipeline landscape. Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. HD is a familial disease ... Read More
-
Saudi Arabia Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New-born Screening, Predictive & Pre-symptomatic Testing, Prenatal Testing, Others), By Disease (Sickle Cell Anemia, Thalassemia, Huntington's Disease, Cancer, Others), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals), By Region, Competition Forecast & Opportunities, 2027
... Testing, Molecular Testing), By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals), By Region, Competition Forecast & Opportunities, 2027 Saudi Arabia genetic testing market is projected to register growth at a significant ... Read More
-
Huntingtin (Huntington Disease Protein or HTT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022'; Huntingtin (Huntington Disease Protein or HTT) pipeline Target constitutes close to 30 molecules. Out of which approximately 27 molecules are developed by companies and remaining by the universities/institutes. Huntingtin (Huntington Disease Protein or ... Read More
-
Brain Monitoring Market Analysis and Forecast to 2031: By Product Type (Electroencephalography Devices, Magnetencephalography Devices, Transcranial Doppler Devices, Intracranial Pressure Monitor, Cerebral Oximeters, Magnetic Resonance Imaging Devices, Computerized Tomography Devices, Positron Emission Tomography Devices, Sleep Monitoring Devices, Electromyography Devices, Accessories), Procedure (Invasive, Non-invasive), Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington’s Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), and Region
... Monitoring Devices, Electromyography Devices, Accessories), Procedure (Invasive, Non-invasive), Application (Epilepsy, Dementia, Parkinson’s Disease, Huntington’s Disease, Headache Disorders, Stroke, Traumatic Brain Injuries, Sleep Disorders, Other Diseases), and Region The global brain monitoring market size was USD ... Read More
-
Global Brain Biomarkers Market Size study, By Product Type (Biomarker Test Kits, Biomarker Analyzers), By Disease Indication (Stroke, MND & ALS, Alzheimer’s Disease & Other Dementias, Parkinson’s Disease, Huntington’s Disease), By Application (Diagnosis, Drug Discovery and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028
... and Development, Others), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories) and Regional Forecasts 2022-2028 Global Brain Biomarkers Market is valued approximately USD XX million in 2021 and is anticipated to grow ... Read More
-
The 2023-2028 World Outlook for Huntington's Disease Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Huntington Disease Treatment Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis
... neurodegenerative disease driven by an expansion of a repeating CAG triplet series in the huntingtin gene (HTT) on chromosome 4, which results in a protein with an abnormally long polyglutamine sequence. Moreover, HD is one ... Read More
-
Huntington Disease - Global Clinical Trials Review, 2022
... data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Huntington's Disease - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Huntington's Disease market report provides current treatment practices, emerging drugs, Huntington's Disease market share of the individual therapies, current and forecasted Huntington's Disease ... Read More
-
Huntington's Disease - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Huntington's Disease Understanding The DelveInsight Huntington's Disease ... Read More
Research Assistance
